Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (211-220 of 356) with videos related to

Pageof 36
Sort By:
The European Respiratory Journal|November 17, 2018
No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidoneLuca Richeldi, Sophie Fletcher, Huzaifa Adamali, et al.
The Lancet. Respiratory Medicine|December 10, 2016
The diagnosis of idiopathic pulmonary fibrosis: current and future approachesFernando J Martinez, Alison Chisholm, Harold R Collard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidenceLuca Richeldi, Francesco Varone, Miguel Bergna, et al.
Respiration; International Review of Thoracic Diseases|November 11, 2022
Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 YearsMichele Mondoni, Fausta Alfano, Francesco Varone, et al.
Pulmonology|January 30, 2025
Ultrathin bronchoscopy-guided small airway biopsy for diagnosing sarcoidosis: A prospective studyRocco Trisolini, Giovanni Sotgiu, Alessandra Cancellieri, et al.
The European Respiratory Journal|April 20, 2019
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke studyGiacomo Sgalla, Anna Rita Larici, Antonina Re, et al.
Archivos De Bronconeumologia|March 9, 2023
Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With NintedanibMichele Mondoni, Francesco Varone, Fausta Alfano, et al.
Pediatrics|March 4, 2009
Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescentsBarbara Maria Bergamini, Monica Losi, Francesca Vaienti, et al.
Respirology (Carlton, Vic.)|March 20, 2020
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre studyGiacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2017
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY TrialCarlo Vancheri, Michael Kreuter, Luca Richeldi, et al.
Pageof 36

Showing results (211-220 of 356) with videos related to

Sort By:
Pageof 36
The European Respiratory Journal|November 17, 2018
No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidoneLuca Richeldi, Sophie Fletcher, Huzaifa Adamali, et al.
The Lancet. Respiratory Medicine|December 10, 2016
The diagnosis of idiopathic pulmonary fibrosis: current and future approachesFernando J Martinez, Alison Chisholm, Harold R Collard, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidenceLuca Richeldi, Francesco Varone, Miguel Bergna, et al.
Respiration; International Review of Thoracic Diseases|November 11, 2022
Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 YearsMichele Mondoni, Fausta Alfano, Francesco Varone, et al.
Pulmonology|January 30, 2025
Ultrathin bronchoscopy-guided small airway biopsy for diagnosing sarcoidosis: A prospective studyRocco Trisolini, Giovanni Sotgiu, Alessandra Cancellieri, et al.
The European Respiratory Journal|April 20, 2019
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke studyGiacomo Sgalla, Anna Rita Larici, Antonina Re, et al.
Archivos De Bronconeumologia|March 9, 2023
Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With NintedanibMichele Mondoni, Francesco Varone, Fausta Alfano, et al.
Pediatrics|March 4, 2009
Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescentsBarbara Maria Bergamini, Monica Losi, Francesca Vaienti, et al.
Respirology (Carlton, Vic.)|March 20, 2020
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre studyGiacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2017
Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY TrialCarlo Vancheri, Michael Kreuter, Luca Richeldi, et al.
Pageof 36